Nanocluster-antibody-drug conjugates (NADC) as an intravesical precision theranostic agent for interstitial cystitis
Zhijun Lin, Wanyan Wang, Ding-Xin Liu, Qiwei Liu, Chenyixin Wang, Zhifeng Xu, Zhiming Wu, Xiangfu Zhou, 张晓东, Yong Huang, Qi Zhao, Yang Jiang
This paper develops a nanocluster-antibody-drug conjugate (NADC) for interstitial cystitis, showing it targets NGF-overexpressing bladder lesions and reduces inflammation in rat models.
Biomaterials · Nov 5, 2025Peer-reviewedMicrobiology